Saratov JOURNAL of Medical and Scientific Research

Botulinum toxin — therapeutic effect in cosmetology

Year: 2016, volume 12 Issue: №3 Pages: 521-524
Heading: Dermatovenerology Article type: Review
Authors: Morrison A.V., Bocharova Y.M., Morrison V.V.
Organization: clinic skin and venereal diseases, Saratov State Medical University

This review presents the data from published literatures and the research works conducted by the authors about mechanisms of action of botulinum toxin and its use in the practical medicine (particularly in dermatology and cosmetology). Indications and contraindications of botulinum toxin use in cosmetology are also considered in this work.

1. Shukia HD, Sharma SK. Clostridium botulinum: a bug beauty and weapon. Crit Rev Mcrobiol 2005; 31 (1): 11-18
2. Cross S. A. Botulism — the most poisonous poison. Utah Law review 2009; (3); 230-235. cgi-bin/showfile.exe? CISOROOT=/ehslnam& CISOPTR= 3852&filename=3839.pdf
3. Artemenko AR, Kurenkov AL. Botulinum toxin: yesterday, today and tomorrow. Neuromuscular diseases 2013; (2): 6-18
4. Frank JE. Historical notes on botulism, Clostridium botulinum? Botulinum toxin, and the idea of therapeutic use of toxin. Movement Disorders 2004; 19; 2-6
5. Won CH, Lee HM, Lee WS. Efficacy and safety of a novel botulinum toxin type A product for treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study. Dermatol Surg 2013; 39 (1, Part 2): 171-178
6. Yiannakopoulou E. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology 2015; 95 (1-2): 65-69
7. Aoki KR, Guyer B. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological action. Eur J Neurol 2001; 8 (Suppl 5): 21-29
8. Jahn R, Fasshauer D, Molecular machines governing exocytosis of synaptic vesicles. Nature 2012; 490; 201-710.1038/ naturel13320
9. Simpson LL. Molecular pharmacology of botulinum and tetanus toxins. Ann Rev Parmacol Toxicol 1986; 26: 427-453
10. Mikhailov VV. Botulism. Leningrad: Medicine, 1980; 199 p.
11. Bray JJ, Harris AJ. Dissociation between nerve-muscle transmission and nerve-trophic effects in rat diaphragm using botulinum toxin. J Physiol (Gr Brit) 1975; 253 (1): 53-77
12. Morrison VV. Mechanisms of development of functional and metabolic disorders in different types of skeletal muscles in botulinum intoxication and their pharmacological correction: author's abstract of doctoral dissertation. Moscow, 1988
13. Dressier D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr 2005; 63; 180-185
14. Scott A. B. Botulinum toxin therapy of eye muscle disorders: safety and effectiveness. Ophtalmic Procedures Assessment Recommendation. Ophthalmology 1989; Suppl.: 37-41. PMID 2779991
15. Bihari K. Safety, effectiveness, and duration of effect of Botox after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia. Current Medical Research and Opinion 2005; 21 (3): 433-438
16. Scott AB, Pasricha PJ, Ravich WJ, Kallo AN. Botulinum toxin forachalasia. Lancet 1993; 341 (8839); 244-245
17. Bushara КО, Park DM. Botulinum toxin and sweating. J Neurol Neurosurg and Psychiatry 1994; 57 (11): 1437-1438
18. Clark RP, Berris CE. Botulinum toxin A: a treatment for facial asymmetry caused by facial nerve paralysis. Plastic and Reconstructive Surgery 1989; 84 (2): 353-355
19. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with botulinum-A exotoxin. J Dermatol Surgery and Oncology 1992; 18(1): 17-21
20. Orlova OR, Yakhno NN. Botox usage (botulinum toxin type A) in clinical practice: manual for doctors. Moscow: Catalogue, 2001
21. Giesler М. How Doppelganger Brand images influence the Market Creation Process: Longitudinal insights from the Rise of Botox Cosmetic. J Markeing 2012; 76 (6): 55-68
22. Barannik Ml, Belyanina EO. Botulinum toxin and mimic wrinkles of the upper facial part: analysis and correction of unfavorable esthetic results. Plastic surgery and cosmetology 2010; (2): 251-266
23. Timerbaeva SL. Inefficiency of botulinum therapy: the old problem and the new solutions. Nervous diseases 2015; (4) 6: 28-32
24. Ibrahim О, Keller ЕС, Arndt К.A. Update on botulinum neurotoxin use in aesthetic dermatology. Semin Cutan Med Surg 2014; 33 (4): 152-156
25. Philipp-Dormston W. G. Botulinum toxin in dermatology. Hautarzt 2014; 65 (2): 133-143
26. Artemenko AR, Kurenkov AL, Nikitin SS, Orlova OR. Mechanism of action of botulinum toxin type A. Plastic surgery and cosmetology 2010; (1): 177-187
27. Juzans Р, Cornelia JX, Molgo J, Faille L, et al. Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromuscul Disord 1996; 6 (3): 177-185
28. De Paiva A, Meunier FA, Molgo J. Functional repair of motor endplates after botulinum neurotoxin type A poisoning. Proc Natl Acad Sci USA 1999; 96 (6): 3200-3205. 29. Dodick DW, Turkel CC, DeGryse RE, et al. Onabotulinum toxin for treatment of chronic migaine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT placebo placebo-clinical program. Headache 2010; 50 (6): 921-936). 30. Grundfld A, Murray CA, Solish N. Botulinum toxin for hyperhidrosis: a review. American Dermatology 2009; 10 (2): 87-102. 31. Hanan MEK, Heba MD, Dalia GA, Nehal MF. Efficacy of onabotulinum toxin A (Botox) versus Abobotulinum toxin A (Dysport) using a conversion factor (1:2.5) in treatment of primary palmar hyperhidrosis. Dermatol Res Pract 2013; 2013: 686329. DOI: 10.1155/2013/686329. 32. Lee KYC, Levell NJ. Turning the tide: a history and review of hyperhydrosis treatment. JRSM Open 2014; 5 (1): 1-4. 33. Nicolau PJ, Chaouat M, Mimoun M. Skin, wrinkles and botulism. Ann Readapt Med Phys2003; 46 (6): 361-374. 34. Ravenni RL. Effects of temperature on muscular block induce of botulinum neurotoxin (BoNTA) in humans. Mov Disord 2000; 15 (Suppl 2): 27. 35. Muller K, Mix E, Adib Saberi F, et al. Prevalens of neutralizing antibodies treated with botulinum toxin type A for spasticity. J Neural Transm 2009; 116: 579-585. 36. Orlova OR. Possibilities and perspectives in botulin toxin use in the esthetic medicine. Cosmetics and medicine 2005; (2): 38-43. Russian (Орлова О. P. Возможности и перспективы применения ботулотоксина в эстетической медицине. Косметика и медицина 2005; (2): 38-43. 37. Emer J, Waldorf Н. Injectable neurotoxins and fillers: there is no free lunch. Injactable methods in cosmetology 2012; (1): 86-99. Russian (ЭмерД., УолдорфХ. Инъекционные ней-ротоксины и филлеры: «бесплатный сыр бывает только в мышеловке». Инъекционные методы в косметологии 2012; (1): 86-99).

2016_03-1_521-524.pdf249.53 KB

No votes yet